Gain Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GANX research report →
About the company
Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments.
- CEO
- Gene Mack
- IPO
- 2021
- Employees
- 23
- HQ
- Bethesda, MD, US
Price Chart
- Market Cap
- $81.47M
- P/E
- -3.29
- P/S
- 0.00
- P/B
- 5.76
- EV/EBITDA
- -3.25
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -201.43%
- ROIC
- -130.70%
- Revenue
- $0 · 0.00%
- Net Income
- $-20,161,099 · 1.23%
- EPS
- $-0.61 · 31.46%
- Op Income
- $-18,710,702
- FCF YoY
- 2.28%
- 52W High
- $4.34
- 52W Low
- $1.41
- 50D MA
- $1.82
- 200D MA
- $2.20
- Beta
- 0.16
- Avg Volume
- 847.49K
Get TickerSpark's AI analysis on GANX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 24, 26 | Mack Gene | other | 200,000 |
| Mar 24, 26 | Fuggetta Gianluca | other | 50,000 |
| Jun 24, 25 | Islam Khalid | other | 15,000 |
| Jun 24, 25 | Nicaise Claude | other | 15,000 |
| Jun 24, 25 | Riley Jeffrey Scott | other | 15,000 |
| Jun 24, 25 | RICHMAN ERIC I | other | 15,000 |
| Jun 24, 25 | HASLER HANS PETER | other | 15,000 |
| Jun 24, 25 | GOLDSTEIN DOV A MD | other | 15,000 |
| Jun 24, 25 | Melincoff Gwen A | other | 15,000 |
| Mar 20, 25 | Fuggetta Gianluca | other | 50,000 |
Our GANX coverage
Recent articles, reports, and earnings notes.
No research on GANX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GANX report →Similar companies
Peers in the same neighborhood.